Artwork

Content provided by Health Media Now. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Health Media Now or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

HEALTH MEDIA NOW-DR. DAVID HAVA-TRENDS TO WATCH IN INHALED DRUG DELIVERY

47:00
 
Share
 

Manage episode 166188680 series 1089031
Content provided by Health Media Now. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Health Media Now or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Please join us this Thursday, November17, 2016 at 4:00 p.m. PST and 7:00 p.m. EST for a live show with host Denise Messenger. Our special guest is Dr. David Hava. He is the Chief Scientific Officer at Pulmatrix Inc. As CSO, Dr. Hava leads the Research and Development organization in the development of inhalation products in the iSPERSE dry powder delivery platform. In addition, Dr. Hava directs and manages the company’s therapeutic strategy to identify and prioritize drug targets and drugs that are enabled by the iSPERSE dry powder delivery platform. Dr. Hava joined Pulmatrix in 2006 as one of the first Senior Scientists and has been involved in the early stage research and development programs that identified and characterized several of the key aspects of the Pulmatrix technology. Dr. Hava earned his PhD. in Molecular Biology and Microbiology at Tufts University and completed his post-doctoral training studying immunology and host-pathogen interactions at Harvard Medical School.
  continue reading

282 episodes

Artwork
iconShare
 
Manage episode 166188680 series 1089031
Content provided by Health Media Now. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Health Media Now or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Please join us this Thursday, November17, 2016 at 4:00 p.m. PST and 7:00 p.m. EST for a live show with host Denise Messenger. Our special guest is Dr. David Hava. He is the Chief Scientific Officer at Pulmatrix Inc. As CSO, Dr. Hava leads the Research and Development organization in the development of inhalation products in the iSPERSE dry powder delivery platform. In addition, Dr. Hava directs and manages the company’s therapeutic strategy to identify and prioritize drug targets and drugs that are enabled by the iSPERSE dry powder delivery platform. Dr. Hava joined Pulmatrix in 2006 as one of the first Senior Scientists and has been involved in the early stage research and development programs that identified and characterized several of the key aspects of the Pulmatrix technology. Dr. Hava earned his PhD. in Molecular Biology and Microbiology at Tufts University and completed his post-doctoral training studying immunology and host-pathogen interactions at Harvard Medical School.
  continue reading

282 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide